262 related articles for article (PubMed ID: 17931789)
1. Lysophospholipid signaling: beyond the EDGs.
Valentine WJ; Fujiwara Y; Tsukahara R; Tigyi G
Biochim Biophys Acta; 2008 Mar; 1780(3):597-605. PubMed ID: 17931789
[TBL] [Abstract][Full Text] [Related]
2. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation.
Lee CW; Rivera R; Dubin AE; Chun J
J Biol Chem; 2007 Feb; 282(7):4310-4317. PubMed ID: 17166850
[TBL] [Abstract][Full Text] [Related]
3. Role of lysophospholipid growth factors in the modulation of aqueous humor outflow facility.
Mettu PS; Deng PF; Misra UK; Gawdi G; Epstein DL; Rao PV
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2263-71. PubMed ID: 15223804
[TBL] [Abstract][Full Text] [Related]
4. Cell surface receptors in lysophospholipid signaling.
Anliker B; Chun J
Semin Cell Dev Biol; 2004 Oct; 15(5):457-65. PubMed ID: 15271291
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells.
Gibbs TC; Rubio MV; Zhang Z; Xie Y; Kipp KR; Meier KE
Prostate; 2009 Oct; 69(14):1493-506. PubMed ID: 19536794
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing.
Lee H; Goetzl EJ; An S
Am J Physiol Cell Physiol; 2000 Mar; 278(3):C612-8. PubMed ID: 10712250
[TBL] [Abstract][Full Text] [Related]
7. beta-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts.
Gesty-Palmer D; El Shewy H; Kohout TA; Luttrell LM
J Biol Chem; 2005 Sep; 280(37):32157-67. PubMed ID: 16027114
[TBL] [Abstract][Full Text] [Related]
8. Current progress in non-Edg family LPA receptor research.
Yanagida K; Kurikawa Y; Shimizu T; Ishii S
Biochim Biophys Acta; 2013 Jan; 1831(1):33-41. PubMed ID: 22902318
[TBL] [Abstract][Full Text] [Related]
9. EDG-1 links the PDGF receptor to Src and focal adhesion kinase activation leading to lamellipodia formation and cell migration.
Rosenfeldt HM; Hobson JP; Maceyka M; Olivera A; Nava VE; Milstien S; Spiegel S
FASEB J; 2001 Dec; 15(14):2649-59. PubMed ID: 11726541
[TBL] [Abstract][Full Text] [Related]
10. The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities.
Takuwa Y; Takuwa N; Sugimoto N
J Biochem; 2002 Jun; 131(6):767-71. PubMed ID: 12038970
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid inhibits Ca2+ signaling in response to epidermal growth factor receptor stimulation in human astrocytoma cells by a mechanism involving phospholipase C(gamma) and a G(alphai) protein.
Hernández M; Barrero MJ; Crespo MS; Nieto ML
J Neurochem; 2000 Oct; 75(4):1575-82. PubMed ID: 10987838
[TBL] [Abstract][Full Text] [Related]
12. Stimulatory actions of lysophosphatidic acid on mouse ATDC5 chondroprogenitor cells.
Itoh R; Miura S; Takimoto A; Kondo S; Sano H; Hiraki Y
J Bone Miner Metab; 2010 Nov; 28(6):659-71. PubMed ID: 20458606
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid as a mediator for proinflammatory agonists in a human corneal epithelial cell line.
Zhang Z; Liu Z; Meier KE
Am J Physiol Cell Physiol; 2006 Nov; 291(5):C1089-98. PubMed ID: 16760261
[TBL] [Abstract][Full Text] [Related]
14. Non-Edg family LPA receptors: the cutting edge of LPA research.
Yanagida K; Ishii S
J Biochem; 2011 Sep; 150(3):223-32. PubMed ID: 21746769
[TBL] [Abstract][Full Text] [Related]
15. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate.
Goetzl EJ; An S
FASEB J; 1998 Dec; 12(15):1589-98. PubMed ID: 9837849
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.
Bandoh K; Aoki J; Hosono H; Kobayashi S; Kobayashi T; Murakami-Murofushi K; Tsujimoto M; Arai H; Inoue K
J Biol Chem; 1999 Sep; 274(39):27776-85. PubMed ID: 10488122
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax.
Goetzl EJ; Kong Y; Mei B
J Immunol; 1999 Feb; 162(4):2049-56. PubMed ID: 9973477
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid signals through mitogen-activated protein kinase-extracellular signal regulated kinase in ovarian theca cells expressing the LPA1/edg2-receptor: involvement of a nonclassical pathway?
Budnik LT; Brunswig-Spickenheier B; Mukhopadhyay AK
Mol Endocrinol; 2003 Aug; 17(8):1593-606. PubMed ID: 12730329
[TBL] [Abstract][Full Text] [Related]
19. Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2).
Contos JJ; Ishii I; Fukushima N; Kingsbury MA; Ye X; Kawamura S; Brown JH; Chun J
Mol Cell Biol; 2002 Oct; 22(19):6921-9. PubMed ID: 12215548
[TBL] [Abstract][Full Text] [Related]
20. Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator.
Takuwa Y; Okamoto H; Takuwa N; Gonda K; Sugimoto N; Sakurada S
Mol Cell Endocrinol; 2001 May; 177(1-2):3-11. PubMed ID: 11377814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
